Skip to main content

Table 2 Comparison of patient characteristics between the flurbiprofen group and non-flurbiprofen group

From: Efficacy of flurbiprofen axetil for preventing postanesthetic shivering in patients undergoing gynecologic laparotomy surgeries

  Flurbiprofen group (n = 31) Non-flurbiprofen group (n = 110) p value
Age (year) 48 ± 15 (21-84) 49 ± 13 (24-84) 0.850
Body mass index (kg/m2) 25.0 ± 6.1 (16.4-46.1) 23.3 ± 4.3 (16.0-36.0) 0.155
Co-morbidities
 Hypertension 8 (25.8) 18 (16.4) 0.231
 Diabetes mellitus 2 (6.5) 6 (5.5) 0.832
 Bronchial asthma 2 (6.5) 17 (15.5) 0.195
Malignancy 17 (54.8) 53 (48.2) 0.513
Operation time (min) 140 ± 56 (47-319) 144 ± 56 (55-356) 0.703
Anesthesia time (min) 199 ± 60 (108-381) 207 ± 67 (103-458) 0.429
Blood loss (g) 438 ± 539 (5-2316) 452 ± 556 (6-3519) 0.831
Fluid infusion (ml/kg/h) 9.9 ± 3.7 (5.2-16.5) 8.7 ± 3.0 (3.4-16.7) 0.169
Fentanyl dosage (μg/kg) 4.4 ± 1.9 (1.3-10.9) 4.4 ± 1.7 (0.9-9.8) 0.685
Remifentanil dosage (mg) 1.9 ± 1.0 (0.8-6.0) 2.0 ± 0.9 (0.8-6.0) 0.616
Body temperature (°C)
 Highest body temperature 36.8 ± 0.4 (36.1-38.0) 36.8 ± 0.4 (35.8-37.8) 0.614
 Lowest body temperature 36.4 ± 0.4 (35.5-37.2) 36.3 ± 0.4 (35.1-37.3) 0.431
Epidural analgesia 26 (83.9) 101 (91.8) 0.191
Postanesthetic shivering 2 (6.5) 28 (25.5) 0.022
  1. The data are given as patient’s number (%) or the mean ± standard deviation (range)